James Holloway advises companies and trade associations on FDA regulation of cosmetic, food, dietary supplement, drug, and medical device products as well as advertising and consumer protection law. With a focus on consumer products, James regularly counsels clients on how to minimize FDA, FTC, state, and consumer class action risks while advancing their business objectives. His practice encompasses issues related to product labeling and marketing, favorable regulatory classifications, Proposition 65, mobile medical applications, strategic engagement with regulators and legislators, and FDA’s implementation of the Modernization of Cosmetics Regulation Act (MoCRA).

James also advises on a range of advertising and consumer protection issues including influencers, claim substantiation, and green claims. He also has experience representing clients before the NAD and in investigations conducted by the FTC regarding product marketing practices.